Rocket Pharmaceuticals, Inc. - RCKT

About Gravity Analytica
Recent News
- 05.27.2025 - Update on Phase 2 Clinical Trial of RP-A501 for Danon Disease
- 05.27.2025 - Rocket Pharmaceuticals Provides Update on Phase 2 Clinical Trial of RP-A501 for Danon Disease
Recent Filings
- 05.27.2025 - 8-K Current report
- 05.27.2025 - EX-99.1 EX-99.1
- 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
- 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
- 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
- 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
- 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
- 05.20.2025 - 144 Report of proposed sale of securities
- 05.20.2025 - 144 Report of proposed sale of securities
- 05.20.2025 - 4 Statement of changes in beneficial ownership of securities